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Abstract 
A microfluidic device based on the differential measurement of the ionic resistance of a micropore for detection of aggregates of 
antibodies in biopharmaceutical downstream process is presented. The main novelty of this contribution regards the experimental 
demonstration that, despite the poor solidness of proteins, their aggregates, in their standard production buffer, can be electrically 
detected down to 2.4 µm diameter with sub-ms transit time (flow rate of 5 µl/min). Thanks to the simple PDMS fluidic 
fabrication, compact DC readout circuit and convenient use of the same metallic silver tubing for both electrical and fluidic 
interconnection, the device can be straightforwardly parallelized in tens of units, thus combining single micrometric sensitivity 
with larger flow rates (>100 µl/min), suitable for in-line installation in pharmaceutical plants. 
© 2016 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of the organizing committee of the 30th Eurosensors Conference. 
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1. Introduction 
The efforts oriented to bringing microfluidic technology from the laboratory to the industry can be classified into 
material development lines, including for instance new patternable materials more suitable for large-scale 
manufacturing [1], as well as actions aiming at the simplification and standardization of the interfaces between the 
chip and the rest of the world and of the instrumentation required for the lab-on-chip autonomous operation. Within 
the last category, we present here the design and experimental validation of a novel microfluidic device for label-free 
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and real-time detection of quality of the production of biopharmaceutical products during the purification phase, the 
bottleneck [2] in alternative to standard chromatographic techniques [3]. In particular, the formation of aggregates of 
antibodies (with cluster diameter in the 1-10 µm range) during the fabrication of biopharmaceuticals represents a 
critical issue in terms of yield and must be carefully monitored [4]. The peculiarities of this system are: (i) direct 
installation in the pharmaceutical pipeline, (ii) unsupervised continuous operation [5], (iii) processing of large flow 
rates (100 µl/min), in contrast with the typical volumes handled in microfluidic systems. In order to address the last 
point, i.e. to combine the sensitivity to single micrometric clusters, granted by a micrometric cross section, with 
large total flow rate, several microfluidic devices are operated in parallel. Thus, the complexity in terms of readout 
electronics and interconnections should be minimized. 
2. Device design 
Starting from the assumption (eventually verified by means of the fabricated device) that the aggregates of 
antibodies behave like insulating bodies with respect to the surrounding ionic medium, we chose a Coulter-counter 
approach implemented in current mode. A voltage V1 is applied across a micrometric constriction and the 
translocation of the particle occluding the pore produces a current drop proportional to the particle volume. We have 
optimized the size of a micropore (Fig. 1a, 10 u 25 u16 µm3), with the support of FEM simulations, maximizing the 
SNR and balancing the speed/resolution trade-off in order to maximize also the flow rate Q. We opted for a 
differential configuration consisting of two micropores fed in parallel and biased by opposite potential V1 = -V2 (Fig. 
1b), allowing: (i) double total flow rate, (ii) immunity the common mode drifts (for instance due to temperature or 
salinity gradients) and disturbance, (iii) lower dynamic range required by the transimpedance amplifier (TIA) and 
(iv) reduction of the impact of the voltage generator noise [6]. 
Another novelty of this work is the use of the same metallic pins (silver tubes) for both fluidic interconnection 
and measuring electrodes (Fig. 2). The differential bias is periodically reversed (every 5 seconds) in order to grant 
long-term operation of the chlorinated Ag electrodes, while the voltage bias values V1 and V2 can be finely adjusted 
to compensate the mismatch between the two device branches (Rpore a150 kΩ ± 10%).  
 
Fig. 1. Aggregate detector based on a micrometric constriction (a), arranged in differential configuration (b) where 
the differential current idiff is amplified by a TIA (c) and acquired (d). Each particle produces a resistive pulse 
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3. Experimental results 
Prior to the use of antibodies cluster of unknown electrical properties, the device has been validated in PBS 
solution (σ = 1.5 S/m) with polystyrene beads of different calibrated diameters (8, 5 and 2 µm). As reported in Fig. 
3, a good size discrimination capability down to a minimum detectable diameter of a2 µm (at Q = 10 µl/min, with a 
SNR = 3 and counting rate up to 1 kbeads/s) is demonstrated. It is comparable with what achievable with 
sophisticated state-of-the-art resonant detectors [7].  
Then, the pharmaceutical buffer alone has been characterized, showing a conductivity of 0.35 S/m (i.e. aPBS/4) 
and no peaks (Fig. 4a), thus showing the absence of impurities. The observed periodical bipolar spikes correspond to 
the bias inversion transients and are not sampled by the acquisition system. Instead, when the buffer containing 
partially purified antibodies (provided by Lek Pharmaceuticals) is injected in the device, resistive pulses are clearly 
detected (Fig. 4b) down to a minimum estimated diameter of 2.4 µm at Q= 5 µl/min. The measured shape of a single 
peak (Fig. 4c) is asymmetric due to the asymmetry of the pore tapered access sides (Fig. 1a) and in good agreement 
with numerical simulations (Fig. 4d). The statistical analysis of a1500 events shows a distribution of peak 
amplitudes (Fig. 4e) consistent with a typical of natural aggregation processes: there is a higher concentration of 
smaller aggregates. The largest detected diameter is a7 µm, demonstrating the potential to cover the 2-10 µm range. 
 
 
Fig. 2. (a) Photograph of the assembled device in the test setup (including a syringe pump and a Faraday cage),
showing the use of Ag/AgCl pins serving (b) as both electrodes and fluidic interconnections between the PDMS





















Fig. 3. Scatter plot of the validation tests with calibrated polystyrene beads of 8, 5 and 2 µm diameter (Q=10 µl/min,
V1=1 V) in PBS solution (σPB =1.5 S/m) showing a linear dependence of the pulse amplitude with the bead volume 
and straightforward sorting capability down to 2 µm (SNR=3). 
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The distribution of pulse durations (Fig. 4f) is consistent with a parabolic velocity profile typical of the laminar flow 
inside the channel: the maximum velocity doubles the average (average pulse width is 100 µs), with the aggregates 
travelling close to walls experiencing a less probable and longer transit time. As expected, it was also verified that 
the amount of observed peaks was related to the temperature and to the thawing speed. At a temperature of 23°C, an 
average of 0.05 peaks/s are counted, while at 37°C and 60°C, the counts increase to 1.8 peaks/s and 16 peaks/s 
respectively. 
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Fig. 4. Comparison between the absence (a) and the presence of aggregates of antibodies in their buffer (b), 
demonstrating single particles sensitivity (c), matching numerical simulations (d), down to a minimum detectable 
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